Medtronic Announces Exclusive U.S. Distribution Deal for Advanced Peripheral Guidewires

Reuters
15 Jul
Medtronic Announces Exclusive U.S. Distribution Deal for Advanced Peripheral Guidewires

Medtronic plc has announced a new exclusive U.S. distribution agreement with Japan-based Future Medical Design Co., Ltd. (FMD) to sell specialty and workhorse peripheral guidewires. This agreement introduces the first 400 cm, 0.018" peripheral guidewire available in the U.S, enhancing Medtronic's offerings for transradial access in treating peripheral arterial disease (PAD). Medtronic will distribute 10 new F-14™* and F-18™* peripheral stainless steel guidewires in 300 cm and 400 cm lengths, providing a comprehensive suite of tools for physicians. These guidewires are designed for crossability, trackability, and tip retention, facilitating complex interventions. This development marks a significant advancement in Medtronic's portfolio, further equipping physicians with essential tools for lower extremity interventions and transradial approaches.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief on July 15, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10